Get all your news in one place.
100's of premium titles.
One app.
Start reading
Manchester Evening News
Manchester Evening News
National
Helen Carter

Covid vaccine calculator shows where you are in queue for jab

The announcement that millions more adults will be offered a coronavirus vaccine in the UK may make you wonder when you are likely to be offered yours.

The government announced on February 26 the phase two priority roll out, with people in their 40s next in line.

The UK began rolling out the vaccine on December 8.

So far, more than 19 million people have already received the first and second dose of either the Oxford/AstraZeneca jab or the Pfizer/BioNTech one.

Vaccine take-up has been high too, at more than 90 per cent, a Downing Street briefing heard on Monday night.

Certain groups are being prioritised, but the government has vowed to have every adult vaccinated by July.

You can see where you are in the queue by using our vaccine calculator:

The phase one list is as follows, in order of priority:

1) Residents in a care home for older adults and their carers

2) All those 80 years of age and over and frontline health and social care workers

3) All those 75 years of age and over

4) All those 70 years of age and over and clinically extremely vulnerable individuals

5) All those 65 years of age and over

6) All individuals aged 16 to 64 years with underlying health conditions which put them at higher risk of serious disease and mortality

7) All those 60 years of age and over

8) All those 55 years of age and over

9) All those 50 years of age and over

Phase two:

1)All those aged 40-49

2) All those aged 30-39

3) All those aged 18-29

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.